220 related articles for article (PubMed ID: 26827257)
21. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
[No Abstract] [Full Text] [Related]
23. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers.
McClure EA; Wahlquist AE; Tomko RL; Baker NL; Carpenter MJ; Bradley ED; Cato PA; Gipson CD; Gray KM
Drug Alcohol Depend; 2021 Aug; 225():108815. PubMed ID: 34171822
[TBL] [Abstract][Full Text] [Related]
24. Monitoring adherence and abstinence of cannabis use disorder patients: Profile identification and relationship with long-term treatment outcomes.
Dacosta-Sánchez D; Fernández-Calderón F; Blanc-Molina A; Díaz-Batanero C; Lozano OM
J Subst Use Addict Treat; 2023 May; 148():209019. PubMed ID: 36933660
[TBL] [Abstract][Full Text] [Related]
25. Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study.
Miranda R; Treloar H; Blanchard A; Justus A; Monti PM; Chun T; Swift R; Tidey JW; Gwaltney CJ
Addict Biol; 2017 May; 22(3):779-790. PubMed ID: 26752416
[TBL] [Abstract][Full Text] [Related]
26. Non-planning Impulsivity But Not Behavioral Impulsivity is Associated with HIV Medication Non-adherence.
Dunne EM; Cook RL; Ennis N
AIDS Behav; 2019 May; 23(5):1297-1305. PubMed ID: 30264205
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
Sherman BJ; McRae-Clark AL
Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
[TBL] [Abstract][Full Text] [Related]
28. N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial.
Kirkland AE; Browning BD; Green R; Liu H; Maralit AM; Ferguson PL; Meyerhoff DJ; Prisciandaro JJ; Miranda R; Brady KT; Tomko RL; Gray KM; Squeglia LM
Neuropsychopharmacology; 2023 Jul; 48(8):1184-1193. PubMed ID: 36878996
[TBL] [Abstract][Full Text] [Related]
29. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
[TBL] [Abstract][Full Text] [Related]
30. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
31. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Roten A; Baker NL; Gray KM
Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
[TBL] [Abstract][Full Text] [Related]
32. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder.
Mills L; Dunlop A; Montebello M; Copeland J; Bruno R; Jefferies M; Mcgregor I; Lintzeris N
Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):67. PubMed ID: 36209081
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
Gray JC; Treloar Padovano H; Wemm SE; Miranda R
J Clin Psychopharmacol; 2018 Apr; 38(2):134-137. PubMed ID: 29424802
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review.
Kondo KK; Morasco BJ; Nugent SM; Ayers CK; O'Neil ME; Freeman M; Kansagara D
Ann Intern Med; 2020 Mar; 172(6):398-412. PubMed ID: 32120384
[TBL] [Abstract][Full Text] [Related]
35. Impulsivity, variation in the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes, and marijuana-related problems.
Bidwell LC; Metrik J; McGeary J; Palmer RH; Francazio S; Knopik VS
J Stud Alcohol Drugs; 2013 Nov; 74(6):867-78. PubMed ID: 24172113
[TBL] [Abstract][Full Text] [Related]
36. Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth.
Cooke ME; Knoll SJ; Streck JM; Potter K; Lamberth E; Rychik N; Gilman JM; Evins AE; Schuster RM
Drug Alcohol Depend; 2024 Mar; 256():111096. PubMed ID: 38277735
[TBL] [Abstract][Full Text] [Related]
37. Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence.
Baumer AM; Nestor BA; Potter K; Knoll S; Evins AE; Gilman J; Kossowsky J; Schuster RM
Drug Alcohol Depend; 2023 Nov; 252():110989. PubMed ID: 37839357
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment.
Yip SW; DeVito EE; Kober H; Worhunsky PD; Carroll KM; Potenza MN
Drug Alcohol Depend; 2014 Jul; 140():33-41. PubMed ID: 24793365
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation as a correlate of cannabis use and problem use.
Lopez-Vergara HI; Jackson KM; Meshesha LZ; Metrik J
Addict Behav; 2019 Aug; 95():138-144. PubMed ID: 30913511
[TBL] [Abstract][Full Text] [Related]
40. Trajectories of impulsivity by sex predict substance use and heavy drinking.
Martinez-Loredo V; Fernandez-Hermida JR; De La Torre-Luque A; Fernandez-Artamendi S
Addict Behav; 2018 Oct; 85():164-172. PubMed ID: 29910036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
